Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats

Food and Chemical Toxicology

Volumn 50, Issue 12, 2012, Pages 4239-4245

  Lee, Tae Hwa ^a   Jung, Chang Hwa ^b   Lee, Dae Hee ^c  

^a Kosin University   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Anti inflammatory; Matrix metalloproteinase; Microglial; Middle cerebral artery occlusion; Schisandra; Schisandrin B

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; SCHIZANDRIN B; TUMOR NECROSIS FACTOR ALPHA;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME DEGRADATION; FRUIT; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION; SCHISANDRA;

ANIMALS; ANTIOXIDANTS; CEREBRAL INFARCTION; CYCLOOCTANES; DRUGS, CHINESE HERBAL; INFLAMMATION; INTERLEUKIN-1BETA; ISCHEMIC ATTACK, TRANSIENT; LIGNANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS; POLYCYCLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION; SCHISANDRA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS; RODENTIA; SCHISANDRA;

EID: 84866669177     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.08.047     Document Type: Article

References (57)

1. Asensi M., Medina I., Ortega A., Carretero J., Bano M.C., Obrador E., Estrela J.M. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radical Biol. Med. 2002, 33:387-398.
2. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia 1993, 7:111-118.
3. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 1999, 19:819-834.
4. Belayev L., Busto R., Zhao W., Ginsberg M.D. HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke 1995, 26:2313-2319.
5. Belayev L., Alonso O.F., Busto R., Zhao W., Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture: neurological and pathological evaluation of an improved model. Stroke 1996, 27:1616-1623.
6. Bitsch A., Kuhlmann T., Da Costa C., Bunkowski S., Polak T., Bruck W. Tumor necrosis factor-α mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia 2000, 29:366-375.
7. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 1992, 587:250-256.
8. Chen N., Chiu P.Y., Ko K.M. Schisandrin B enhances cerebral mitochondrial antioxidant status and structural integrity, and protects against cerebral ischemia/reperfusion injury in rats. Biol. Pharm. Bull. 2008, 31:1387-1391.
9. Chiu P.Y., Ko K.M. Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats. Mol. Cell. Biochem. 2004, 266:139-144.
10. Chiu P.Y., Leung H.Y., Poon M.K., Ko K.M. Chronic Schisandrin B treatment improves mitochondrial antioxidant status and tissue heat shock protein production in various tissues of young adult and middle-aged rats. Biogerontology 2006, 7:199-210.
11. Davies C.A., Loddick S.A., Stroemer R.P., Hunt J., Rothwell N.J. An integrated analysis of the progression of cell responses induced by permanent focal middle cerebral artery occlusion in the rat. Exp. Neurol. 1998, 154:199-212.
12. De Ryck M., Van Reempts J., Borgers M., Wauquier A., Janssen P.A. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke 1989, 20:1383-1390.
13. Dejonckheere E., Vandenbroucke R.E., Libert C. Matrix metalloproteinases as drug targets in ischemia/reperfusion injury. Drug Discov. Today 2011, 16:762-778.
14. Egashira N., Yuzurihara M., Hattori N., et al. Ninjin-yoei-to (Ren-Shen-Yang-Rong-Tang) and polygalae radix improves scopolamine-induced impairment of passive avoidance response in mice. Phytomedicine 2003, 10:467-473.
15. Feuerstein G.Z., Wang X., Barone F.C. The role of cytokines in the neuropathology of stroke and neurotrauma. NeuroImmunoModulation 1998, 5:143-159.
16. Fujihashi T., Hara H., Sakata T., Mori K., Higuchi H., Tanaka A., Kaji H., Kaji A. Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new non-nucleoside inhibitors of HIV type 1 reverse transcriptase. Antimicrob. Agents Chemother. 1995, 39:2000-2007.
17. Garcia J.H., Wagner S., Liu K.F., Hu X.J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995, 26:627-634.
18. Gasche Y., Fujimura M., Morita-Fujimura Y., Copin J., Kawase M., Massengale J., et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 1999, 19:1020-1028.
19. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Rev. 1995, 20:269-287.
20. Gilgun-Sherki Y., Rosenbaum Z., Melamed E., Offen D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev. 2002, 54:271-284.
21. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A.Y., Lipton S.A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 2005, 25:6401-6408.
22. Hikino H., Kiso Y., Taguchi H., Ikeya Y. Antihepatotoxic actions of lignoids from Schisandra chinensis fruits. Planta Med. 1984, 50:213-218.
23. Ikeya Y., Taguchi H., Sasaki H., Nakajima K., Yoshioka I. 13C NMR magnetic resonance spectroscopy of dibenzocyclooctadiene lignans. Chem. Pharm. Bull. 1980, 27:1383-1390.
24. Jin R., Yang G., Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 2010, 87:779-789.
25. Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A.M., Le Diguardher T., Khrestchatisky M., Rivera S. Neuronal activity dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur. J. Neurosci. 2003, 18:1507-1517.
26. Kiso Y., Tohkin M., Hikino H., Ikeya Y., Taguchi H. Mechanism of antihepatotoxic activity of wuweizisu C and gomisin A. Planta Med. 1985, 51:331-334.
27. Ko K.M., Yiu H.Y. Schisandrin B modulates the ischemia-reperfusion induced changes in non-enzymatic antioxidant levels in isolated-perfused rat hearts. Mol. Cell. Biochem. 2001, 220:141-147.
28. Ko K.M., Ip S.P., Poon M.K.T., Wu S.S., Che C.T., Ng K.H., Kong T.C. Effect of a lignan-enriched Fructus Schisandrae extract on hepatic glutathione status in rats: protection against carbon tetracholoride toxicity. Planta Med. 1995, 61:134-137.
29. Koh S.H., Park Y., Song C.W., Kim J.G., Kim K., Kim J., Kim M.H., Lee S.R., Kim D.W., Yu H.J., Chang D.I., Hwang S.J., Kim S.H. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals. Eur. J. Neurosci. 2004, 20:1461-1472.
30. Lee S.R., Lo E.H. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 2004, 24:720-727.
31. Lehrmann E., Christensen T., Zimmer J., Diemer N.H., Finsen B. Microglial and macrophage reactions mark progressive changes and define the penumbra in the rat neocortex and striatum after transient middle cerebral artery occlusion. J. Comp. Neurol. 1997, 386:461-476.
32. Liu, G.T., 1985. In: Chang HM, et al. (Eds.), Advances in Chinese Medical Materials Research. Singapore. Chapter Title: Hepato-Pharmacology of Fructus schisandrae. World Scientific Publishing Co., pp. 257-268.
33. Lo E., Wang X., Cuzner M. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J. Neurosci. Res. 2002, 69:1-9.
34. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 2003, 4:399-415.
35. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
36. Maier C.M., Ahern K., Cheng M.L., Lee J.E., Yenari M.A., Steinberg G.K. Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke 1998, 29:2171-2180.
37. Markgraf E.J., Green B.E., Hurwitz E., Morikawa W.D., Dietrich P.M., McCabe M.D., Ginsberg, Schneiderman N. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res. 1992, 575:238-246.
38. Marshall J.F., Bhatnagar A.S., Bowman S.G., Morris N.N., Skorich D.A., Redding C.D., Blikslager A.T. The effects of a novel anti-inflammatory compound (AHI-805) on cyclooxygenase enzymes and the recovery of ischaemia injured equine jejunum ex vivo. Equine Vet. J. 2011, 43:106-111.
39. Martino G., Adorini L., Rieckmann P., Hillert J., Kallmann B., Comi G., Filippi M. Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurol. 2002, 1:499-509.
40. Nakajima K., Taguchi H., Ikeya Y., Endo Y., Yosioka I. The constituents of Schisandra chinensis Baill. XIII. Quantitative analysis of lignans in the fruits of Schisandra chinensis Baill. by high performance liquid chromatography. Yakugaku Zasshi 1983, 103:743-749.
41. Rentzos M., Nikolaou C., Rombos A., Voumvourakis K., Segditsa I., Papageorgiou C. Tumor necrosis factor-α is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies. J. Neurol. 1996, 243:165-170.
42. Rivera S., Ogier C., Jourquin J., Timsit S., Szklarczyk A.W., Miller K., Gearing A.J., Kaczmarek L., Khrestchatisky M. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur. J. Neurosci. 2002, 15:19-32.
43. Rosenberg G., Navratil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 1997, 48:921-926.
44. Rosenberg G.A., Estrada E.Y., Dencoff J.E., Stetler-Stevenson W.G. Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res. 1995, 703:151-155.
45. Rosenberg G.A., Cunningham L.A., Wallace J., Alexander S., Estrada E.Y., Grossetete M., Razhagi A., Miller K., Gearing A. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 2001, 893:104-112.
46. Son S., Lewis B.A. Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. J. Agric. Food Chem. 2002, 50:468-472.
47. Song J.X., Lin X., Wong R.N., Sze S.C., Tong Y., Shaw P.C., Zhang Y.B. Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells. Phytother Res. 2011, 25:435-443.
48. Tu X.K., Yang W.Z., Liang R.S., Shi S.S., Chen J.P., Chen C.M., Wang C.H., Xie H.S., Chen Y., Ouyang L.Q. Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem. Res. 2011, 36:2022-2028.
49. Wang J.P., Raung S.L., Hsu M.F., Chen C.C. Inhibition by gomisin C (a lignan from Schisandra chinensis) of the respiratory burst of rat neutrophils. Br. J. Pharmacol. 1994, 113:945-953.
50. Wang Q., Xu J., Rottinghaus G.E., Simonyi A., Lubahn D., Sun G.Y., Sun A.Y. Resveratrol protects against global cerebra ischemic injury in gerbils. Brain Res. 2002, 958:439-447.
51. Wójcik-Stanaszek L., Sypecka J., Szymczak P., Ziemka-Nalecz M., Khrestchatisky M., Rivera S., Zalewska T. The potential role of metalloproteinases in neurogenesis in the gerbil hippocampus following global forebrain ischemia. PLoS One 2011, 6:e22465.
52. Xue J.Y., Liu G.T., Wei H.L., Pan Y. Antioxidant activity of two dibenzocyclooctene lignans on the aged and ischemic brain in rats. Free Radical Biol. Med. 1992, 12:127-135.
53. Yamada S., Murawaki Y., Kawasaki H. Preventive effect of gomisin A, a lignan component of Schisandra fruits, on acetaminophen-induced hepatotoxicity in rats. Biochem. Pharmacol. 1993, 46:1081-1085.
54. Yasukawa K., Ikeya Y., Mitsuhashi H., Iwasaki M., Aburada M., Nakagawa S., Takeuchi M., Takido M. Gomisin A inhibits tumor promotion by 12-o-tetra-decanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 1992, 49:68-71.
55. Yim T.K., Ko K.M. Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Mol. Cell. Biochem. 1999, 196:151-156.
56. Zhao W., Belayev L., Ginsberg M.D. Transient middle cerebral artery occlusion by intraluminal suture: II. Neurological deficits, and pixel-based correlation of histopathology with local blood t10w and glucose utilization. J. Cereb. Blood Flow Metab. 1997, 17:1281-1290.
57. Zhu M., Lin K.F., Yeung R.Y., Li R.C. Evaluation of the protective effects of Schisandra chinensis on Phase I drug metabolism using a CCl4 intoxication model. J. Ethnopharmacol. 1999, 67:61-68.